In the present study, we demonstrated that pharmacological inhibition of soluble TNF/TNFR1 signaling by XPro1595, but not TNFR1 gene deletion, significantly reduced PNI-associated mechanical hypersensitivity, mitigated tumor progression, and improved motor performance primarily in female mice. Here, TNFRSF1A is linked to neoplasm.